Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: June 6, 2023
Reporting Period: Month of June 2023
This filing serves to furnish documents related to an Extraordinary General Shareholders' Meeting scheduled for June 30, 2023, in Ghent, Belgium. The filing includes convening notices, attendance forms, proxy forms, voting instructions, and a press release dated June 5, 2023.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding a shareholder meeting and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document focuses on corporate governance procedures for the upcoming shareholder meeting.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.6) but does not include the text of that release within the provided content. Therefore, specific management commentary, guidance, or outlook is not available in this summary.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this Form 6-K. The filing explicitly states that the attached exhibits are furnished and not "filed" for purposes of Section 18 of the Exchange Act, limiting their legal liability status.
Key Facts for Investor Verification
- Verify the content of the Press Release dated June 5, 2023 (Exhibit 99.6), as it is referenced but not included in the text.
- Confirm the agenda and voting outcomes of the Extraordinary General Shareholders' Meeting held on June 30, 2023.
- Review the "Outstanding Shares and Voting Rights" (Exhibit 99.5) for capital structure details.
- Note that the attached exhibits are not deemed "filed" under Section 18 of the Exchange Act.